Panobinostat

Tags: Drug.

Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (HDAC inhibitor).

thumbnail

ATC prefix

L01

ATC suffix

XX42

CAS number

404950-80-7

FDA UNII code

9647FM7Y3Z

IUPAC name

(2E)-N-hydroxy-3-[4-([2-(2-methyl-1H-indol-3-yl)ethyl]aminomethyl)phenyl]acrylamide

PubChem

6918837